tm logo
DIRECTDETECT
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 23 Jan 2023

Last Applicant/ Owned by

17062 Murphy Avenue

Irvine

CA

92614

Serial Number

90809208 filed on 02th Jul 2021

Registration Number

N/A

Correspondent Address

Jonathan A Claypool

ZYMO RESEARCH CORPORATION

17062 MURPHY AVENUE

IRVINE CA 92614

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

DIRECTDETECT

Reagent for medical use, namely, for the preservation and immediate analysis of nucleic acids (RNA and DNA) of collected samples, namely, biological fluids or tissues DIRECT DETECT Reagents for scientific and research use, namely, for the preservation and immediate analysis of nucleic acids (RNA and DNA) of collected samples, namely, biological fluids or tissues

Classification Information


Class [001]
Chemical Products


Reagents for scientific and research use, namely, for the preservation and immediate analysis of nucleic acids (RNA and DNA) of collected samples, namely, biological fluids or tissues

Class [005]
Pharmaceutical Products


Reagent for medical use, namely, for the preservation and immediate analysis of nucleic acids (RNA and DNA) of collected samples, namely, biological fluids or tissues

Mark Details


Serial Number

No 90809208

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 4429A

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
23rd Jan 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
23rd Jan 2023ABANDONMENT - NO USE STATEMENT FILED
21st Jun 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
26th Apr 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26th Apr 2022PUBLISHED FOR OPPOSITION
06th Apr 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
21st Mar 2022APPROVED FOR PUB - PRINCIPAL REGISTER
19th Mar 2022TEAS/EMAIL CORRESPONDENCE ENTERED
18th Mar 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
18th Mar 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED